When Your “Why” Finds You Again: The Other Side of the Table

I knew medicine before I understood its mechanisms.

For most of my childhood, we understood my mother’s disease as cystic fibrosis; only later would her diagnosis be revised to primary ciliary dyskinesia. At the time, diagnostic nomenclature meant very little to me. Illness entered my vocabulary through its consequences: pulmonary function, antibiotics, ports, transplantation. Years later, I would learn the language underneath those words: impaired mucociliary clearance, progressive pulmonary disease, alloimmunity, immunosuppression, graft dysfunction. As a child, I understood only the surface of a clinical reality far more complicated than I could appreciate.

My mother, however, was fascinated by what medicine might someday become. I remember her telling me about researchers attempting to grow lungs from cells, imagining a future in which an organ might be engineered for the person who needed it and perhaps circumvent some of the immunologic incompatibility that makes transplantation so difficult. I was too young to appreciate how ambitious that proposition was. What I understood was simpler: medicine was changing, and perhaps she could hold on long enough to benefit from what came next.

Some version of my “why” began there.

Whenever school gave me permission to investigate something freely, I returned to her illness. In middle school, I remember running my fingers along a shelf of books until they stopped on one about cystic fibrosis. Later projects became opportunities to study epidemiology, prognosis, transplantation, and outcomes. Long before I knew how to speak about my mother emotionally, I knew how to research her. Facts were easier to organize than fear, and science gave structure to experiences I did not yet have the language to describe. 

Yet illness was never the organizing principle of my childhood. My mother was.

She seemed almost constitutionally suited to motherhood: loving, steadfast, compassionate, and perpetually concerned about everyone around her. Her illness seemed to frustrate her less because of what it prevented her from doing for herself than because of what it occasionally prevented her from doing for us. She wanted another PTA meeting, another field trip, another recital, another track meet. She wanted to participate in the ordinary architecture of our lives, and she worked remarkably hard to make our home feel ordinary. 

She also told me she would be around for a long time.

For years after she died, some younger part of me occasionally returned to that promise with indignation. She had lied. Adulthood has made that interpretation increasingly difficult to defend. What, exactly, is a mother supposed to tell her five-year-old? That prognosis is probabilistic? That progressive disease can narrow therapeutic options until transplantation becomes less a cure than an exchange of one set of risks for another? That medicine may extend a life without being able to promise its duration?

Of course she told me she would stay.

I understand now that reassurance was not evidence that she lacked fear. It may instead have been evidence of how carefully she contained it. She encountered the uncertainty first, made sense of what she could, and handed me a version that a child could carry. By the time it reached me, uncertainty had been translated into reassurance. I did not understand then what that translation may have required of her. 

Years later, after losing her and eventually finding my way back toward medicine, I entered graduate school. I did not know that my education would return me so directly to transplantation.

Now I sit in rooms where we discuss where transplant medicine has succeeded, where it continues to fall short, and how much remains unresolved. We discuss allograft survival, immune-mediated injury, chronic rejection, organ allocation, adherence, immunosuppressive therapy, and the fundamental biological challenge of asking one human body to tolerate an organ genetically foreign to it. These conversations are not intended to reassure anyone. We examine unfavorable outcomes and persistent gaps precisely because improving them requires describing them without euphemism. 

As a child, I received much of the medicine after someone else had interpreted it. Now, I am expected to interpret it myself.

This is, in many ways, exactly where I wanted to be. I spent years wanting access to these conversations, to the spaces where medicine’s limitations are discussed candidly enough that someone might begin to change them. I wanted to understand the problems my mother and I once talked about from a distance. I wanted to be close to the work.

What I failed to anticipate was that wanting to arrive somewhere and being emotionally prepared for the arrival are not necessarily the same thing.

That realization has become particularly clear during clinical experiences. I often find myself watching the person sitting beside the patient almost as closely as I watch the patient. The designated caregiver listens carefully, takes notes, asks questions, and tries to convert probabilities, contingencies, and unfamiliar terminology into something resembling a plan.

I recognize that person immediately. I understand the vigilance of loving someone whose physiology refuses to become predictable.

What has surprised me more is recognizing my mother in the patient.

I have spent several years working in clinical environments and have met people near both the beginning and the end of life. My family’s experience has always existed somewhere in the background of why medicine matters to me, but until now that connection remained distant enough to intellectualize. Transplantation has collapsed much of that distance. 

I now find myself noticing the uncertainty on patients’ faces. This should not have surprised me, but somehow it did. In the architecture of my childhood, fear belonged to me. My mother occupied another category entirely. She was the person who absorbed fear and returned reassurance. When transplantation became sufficiently real that it required a family conversation, she sat us down with information from the hospital and invited us to ask whatever we wanted.

I remember trying not to cry. I do not remember her doing the same. 

Sitting across from patients confronting their own uncertain futures has forced me to reconsider that memory. My mother knew considerably more than I did. She understood that replacing failing lungs did not eliminate uncertainty so much as reorganize it. Respiratory decline might give way to the possibility of rejection. Immunosuppression introduced susceptibility to infection. Surveillance became routine. An organ could restore a future without guaranteeing its duration.

Then she went home and continued being my mother.

The more medicine I learn, the more difficult it becomes to comprehend the duality of that role. She was simultaneously a patient confronting the limitations of her own body and the person responsible for convincing her children that their world remained secure.

There is a peculiar consequence to acquiring the clinical vocabulary for your own childhood. Knowledge makes memory more legible, but not necessarily lighter. My mother once stood between me and much of what she understood. I now have enough knowledge to better understand what she may have been carrying, but she is no longer here to translate it for me. 

Still, I would not trade being here.

There is something extraordinary about sitting in rooms I once imagined only from a distance. The child who listened to her mother describe scientists attempting to engineer lungs could not have known that one day she would herself participate in conversations about transplantation, immune response, engineering, and the future of medicine. She could not have anticipated the years between those moments, nor that the person who first made those questions important would not be here when she finally learned enough to ask different ones.

There are days when I want nothing more complicated than to call my mother. I want to tell her what I learned and ask which developments would fascinate her now. I want to revisit conversations I remember exclusively from her child's perspective and hear them from hers.

For most of my life, I have known how to ask what happened to her. I know diagnoses, interventions, complications, and outcomes. What I never really learned to ask was something far simpler: how did you feel? 

That question has changed how I understand my “why.”

For years, I described it straightforwardly: I wanted to make a difference in the problems that affected my mother. That remains true. But proximity has expanded what I think making a difference means. Medicine asks us to understand disease at the level of genes, cells, organs, and therapies. It also asks us to understand what uncertainty does to the person inhabiting that biology and to the person sitting beside them.

Perhaps my “why” was never solely about solving a biological problem. It was also about understanding the people living inside one.

I came to this side of the table hoping to understand the medicine. I did not expect that, in doing so, I would begin to understand my mother differently.

Maybe that is the strange thing about a “why.” Sometimes we spend years searching for one, only to discover that it has been quietly changing alongside us. And sometimes, years later, it finds us again.